Back The Guardian Reckitt Benckiser to pay $1.4bn fine over opioid treatment sales
Search Sections 20 Sep
Close
Advertisement
11 Jul 4:36am

Reckitt Benckiser to pay $1.4bn fine over opioid treatment sales

The Guardian
Nurofen maker reaches deal with US over alleged fraudulent marketing of Suboxone Reckitt Benckiser has agreed to pay a $1.4bn (£1.1bn) fine to settle a US investigation into sales of a treatment for addiction to opioids by its former prescription drugs business Indivior. The maker of Nurofen and Durex said it had reached a deal with the US Department of Justice and Federal Trade Commission to resolve the long-running inquiry into sales and marketing of Suboxone Film, an opioid-based drug.
Read full story
 Like Comment
Advertisement

Comments

No comments yet...
On the top

Date settings

Today is Friday, September 20, 2019

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

The Guardian

Close